Heparin assay
Siemens Healthcare is announcing the availability of the new INNOVANCE Heparin Assay for the BCS XP System and the Sysmex CS-2000i, CS-2100i and the CS-5100 Systems. This truly liquid testing solution generates precise results with fewer steps, streamlining workflow with easy-to-use reagents and a single hybrid calibration curve for both unfractionated heparin (UFH) and low molecular weight heparin (LMWH). Non-liquid heparin assays typically require labour-intensive reconstitution and mixing of reagents before testing can occur, impacting laboratory workflow. Unlike other liquid heparin assays that may need to stand for up to 30 minutes before use, the INNOVANCE Heparin Assay can be used immediately. The assay’s single calibration curve for both UFH and LMWH adds confidence to results by eliminating the risk of evaluation on the wrong curve. This new assay is designed to significantly reduce hands-on time and improve security so that heparin testing can become a more routine laboratory operation. Heparin is an anticoagulant used to prevent and treat blood clots in at-risk patients. It exists in two forms, UFH and LMWH, both of which are widely used as prophylactic and therapeutic anticoagulants. The INNOVANCE Heparin Assay utilizes a universal calibrator set that is traceable to the World Health Organization (WHO) standards for UFH and LMWH. Dedicated controls for UFH and LMWH have two levels each, and the hybrid calibration curve includes five levels for greater precision and accuracy. It exhibits excellent correlation between Siemens and Sysmex systems and offers a comparable number of tests per kit across all systems.
Supplier: Siemens Healthineers
Website:
